0
Other Articles |

HEXYLRESORCINOL IN THE TREATMENT OF PYELITIS OF INFANCY AND OF CHILDHOOD

WILLIAM J. SCOTT, M.D.; VEADER LEONARD, M.D.
Am J Dis Child. 1926;31(2):241-249. doi:10.1001/archpedi.1926.04130020093010.
Text Size: A A A
Published online

Because such measures as renal pelvic lavage cannot be employed in young children with the same facility as in adults, a more efficient internal urinary antiseptic, which could be administered by mouth without danger, would seem to be a particularly welcome addition to our present methods of treating the urinary infections of infancy and childhood. It was with great interest, therefore, that we undertook the clinical application of hexylresorcinol in this group of cases.

As has been pointed out,1 hexylresorcinol2 is the substance described as meeting all of the experimental qualifications enumerated by Davis and his co-workers3 as essential to an internal urinary antiseptic. The experimental facts, on which its clinical employment is based, are as follows:

  1. It is a stable chemical compound.

  2. It is nontoxic in therapeutic doses.

  3. It is nonirritating to the urinary tract.

  4. It is bactericidal in high dilution in urine of any reaction.

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs